Special notice
Purity Specifications, Storage and Distribution for Medications Development
75N98026R00136
National Institutes of Health, National Institutes of Health. Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology).
Response deadline
August 14, 2026 at 8:00 PM EDT
Closed 78 days ago. Posted July 30, 2026, first published July 30, 2026. Scheduled to archive September 30, 2026.
Get the next one like this from National Institutes of Health by email, the day it is posted.Find my opportunities
This one closed in 2026
127 like it are open now in research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology)
- Risk Underlying Rural Areas Longitudinal (RURAL) H
National Institutes of Health, National Institutes of Health Olao
SolicitationNAICS 541715Bethesda, MD75N98026R00074Closes in 4 daysNov 5 - Prototype development for Battlefield Wound Infection Prevention and Treatment (BWI P&T) Barrier Combination
Defense Health Agency (Dha), Defense Health Agency
SolicitationNAICS 541715Frederick, MDHT9427-26-R-E020Closes in 5 daysNov 6 - Hubble Space Telescope (HST) Servicing
National Aeronautics and Space Administration, NASA Goddard Space Flight Center
Sources soughtNAICS 541715Greenbelt, MD80GSFC27RFIHSTSCloses in 29 daysNov 30
Description
As published on SAM.gov.
TITLE: Purity Specifications, Storage and Distribution for Medications Development
This is a Sources Sought notice. THIS IS NOT A REQUEST FOR PROPOSALS, ABSTRACTS, OR QUOTATIONS. This notice is for information and planning purposes only and does not commit the Government to any contractual agreement. The Government does not intend to award a contract based on responses under this announcement nor otherwise pay for preparing any information sent for the Government's use. Any proprietary information should be so marked.
PROJECT REQUIREMENTS
The National Institute on Drug Abuse (NIDA) seeks capability statements from small businesses having the in-house capability to act as a centralized repository for compounds (i.e., chemical and biological) from domestic and international investigators, commercial sources, and pharmaceutical companies. Specifically, the project requires the following tasks:
The major goal of this project is to provide NIDA and other NIH Institutes with a holding site which has the capability to inventory, analyze and store compounds, prepared under both non-GMP (Good Manufacturing Practices) and GMP conditions, in amounts ranging from milligram quantities to several kilograms. In accordance with the Controlled Substances Act of 1970, DEA Research Registration for Schedules II to V and potentially Schedule I controlled substances will be required.
Please see the attachment for more details.
Attachments
Files listed on SAM.gov. The ones we hold a copy of download from here; the rest open SAM's download, which needs no account.
- N01DA-27-8961_Sources Sought Notice.pdf123 KB, July 30, 2026
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
July 30, 2026
Special notice
Due August 14, 2026 at 8:00 PM EDT. SAM.gov, notice 05908f794a6a491392de36013cc737de
2 revisions on SAM
- July 30, 2026: publish, special notice
- July 30, 2026: publish, special notice
July 30, 2026
Special notice
Due August 14, 2026 at 8:00 PM EDT. SAM.gov, notice de59e3aea58d42f7a64eb45185acdd2d
2 revisions on SAM
- July 30, 2026: publish, special notice
- July 30, 2026: publish, special notice
Points of contact
- Polina Klimenkovapolina.klimenkova@nih.gov